CWIAX
Price
$81.69
Change
-$0.05 (-0.06%)
Updated
Jun 22 closing price
Net Assets
159.53B
MGQAX
Price
$12.42
Change
-$0.11 (-0.88%)
Updated
Jun 22 closing price
Net Assets
21.62M
Interact to see
Advertisement

CWIAX vs MGQAX

CWIAX vs MGQAX Comparison Chart in %
View a ticker or compare two or three
VS
CWIAX vs. MGQAX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWIAX is a Hold and MGQAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWIAX has more cash in the bank: 160B vs. MGQAX (21.6M). CWIAX pays higher dividends than MGQAX: CWIAX (1.33) vs MGQAX (0.00). CWIAX was incepted earlier than MGQAX: CWIAX (24 years) vs MGQAX (13 years). MGQAX (1.88) is less costly to investors than CWIAX (0.75). MGQAX is a more actively managed with annual turnover of: 49.00 vs. CWIAX (44.00). MGQAX initial investment is less costly to investors than CWIAX (4%) vs CWIAX (4%). CWIAX has a lower initial minimum investment than MGQAX: CWIAX (250) vs MGQAX (1000). CWIAX annual gain was more profitable for investors over the last year : 21.85 vs. MGQAX (-27.95). CWIAX return over 5 years is better than : 38.04 vs. MGQAX (-29.21).
CWIAXMGQAXCWIAX / MGQAX
Total Expense Ratio0.751.1565%
Annual Report Gross Expense Ratio0.751.8840%
Fund Existence24 years13 years-
Gain YTD15.640-4.278-366%
Front Load4%5%67%
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets160B21.6M740,741%
Annual Yield % from dividends1.330.00-
Returns for 1 year21.85-27.95-78%
Returns for 3 years53.22-25.84-206%
Returns for 5 years38.04-29.21-130%
Returns for 10 years132.0310.691,235%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWGSX24.380.15
+0.62%
Nationwide Renaissance Sm Cp Gr InstlSvc
HGHSX42.96N/A
N/A
Hartford Healthcare R4
LMPOX33.42N/A
N/A
ClearBridge Small Cap Growth R
MFRKX59.62N/A
N/A
MFS Research R6
AATIX19.33N/A
N/A
Ancora/Thelen Small-Mid Cap I